![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Relapsed and Refractory AML
1. If remission rates are high in AML, why are many patients not cured? Video
2. What are the strategies for patients who have relapsed? Video
3. BETA - What is the definition of relapsed AML? Video
4. BETA - What is the difference between relapsed and refractory AML? Video
5. How do I know what my risk of relapse is? Video
6. How do I know if my AML has relapsed? Video
7. Why do you become refractory to a drug? Video
8. How often are patients refractory to induction therapy and if this happens, what’s next for these patients? Video
9. What are the next steps if I relapse after taking hypomethylating agents with or without venetoclax? Video
10. Do individuals become refractory to a specific drug or an entire class of drugs? Video
11. If I relapse, is the previous treatment given again or should I consider a new therapy? Video
12. What are the newest drugs for relapsed/refractory AML? Which are some promising drugs in development? Video
13. When should a patient consider a clinical trial if they relapse? Video
14. What are some tips or strategies for coping with the ongoing fear of relapse? Video
If remission rates are high in AML, why are many patients not cured?
Lesson Description
Find out why many AML patients aren't cured, even though remission rates are high.